Effects of liraglutide, a glucagon-like peptide-1 analog, on left ventricular remodeling assessed by cardiac magnetic resonance imaging in patients with ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2015-08-21

AUTHORS

Tsuyoshi Nozue, Masayo Yamada, Tetsuji Tsunoda, Hiromasa Katoh, Shimpei Ito, Taku Iwaki, Ichiro Michishita

ABSTRACT

The clinical efficacy of glucagon-like peptide-1 (GLP-1) analogs in patients with acute myocardial infarction (AMI) is uncertain. The purpose of the present study was to evaluate the effects of the GLP-1 analog liraglutide on left ventricular (LV) remodeling in patients with AMI. We retrospectively evaluated the effects of liraglutide on LV remodeling assessed by cardiac magnetic resonance imaging (CMRI) in 15 patients with type 2 diabetes who were successfully treated with primary percutaneous coronary intervention (PCI) for AMI. Patients were divided into two groups based on their hypoglycemic medication: liraglutide use (group L; n = 6) or standard therapy (group S; n = 9). The CMRI findings in the early phase and at the 6-month follow-up were compared. At the 6-month follow-up, group S showed increases in LV end-diastolic (from 64 to 74 mL/m2, p = 0.08) and end-systolic (from 38 to 45 mL/m2, p = 0.13) volume indexes, whereas no such increase was observed in group L. The LV mass index (LVMI) was significantly smaller in group L than in group S at baseline (64 vs. 75 g/m2, p = 0.05) and at follow-up (56 vs. 78 g/m2, p = 0.009). Multivariate regression analysis showed that liraglutide use was an independent negative predictor of LVMI (β = −0.720, p = 0.003). In conclusion, liraglutide may be able to prevent the progression of LV remodeling and is associated with a lower LV mass in diabetic patients with AMI undergoing primary PCI. More... »

PAGES

1239-1246

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00380-015-0734-5

DOI

http://dx.doi.org/10.1007/s00380-015-0734-5

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1001685894

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/26293570


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diabetes Mellitus, Type 2", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Japan", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Linear Models", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Liraglutide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Magnetic Resonance Imaging", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Multivariate Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Myocardial Infarction", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Percutaneous Coronary Intervention", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pilot Projects", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ventricular Function, Left", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ventricular Remodeling", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Division of Cardiology, Department of Internal Medicine, Yokohama Sakae Kyosai Hospital, Federation of National Public Service Personnel Mutual Associations, 132 Katsura-cho, Sakae-ku, 247-8581, Yokohama, Japan", 
          "id": "http://www.grid.ac/institutes/grid.417368.f", 
          "name": [
            "Division of Cardiology, Department of Internal Medicine, Yokohama Sakae Kyosai Hospital, Federation of National Public Service Personnel Mutual Associations, 132 Katsura-cho, Sakae-ku, 247-8581, Yokohama, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nozue", 
        "givenName": "Tsuyoshi", 
        "id": "sg:person.01033145125.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01033145125.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Metabolism and Endocrinology, Department of Internal Medicine, Yokohama Sakae Kyosai Hospital, Yokohama, Japan", 
          "id": "http://www.grid.ac/institutes/grid.417368.f", 
          "name": [
            "Division of Metabolism and Endocrinology, Department of Internal Medicine, Yokohama Sakae Kyosai Hospital, Yokohama, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yamada", 
        "givenName": "Masayo", 
        "id": "sg:person.01171603660.78", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01171603660.78"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Metabolism and Endocrinology, Department of Internal Medicine, Yokohama Sakae Kyosai Hospital, Yokohama, Japan", 
          "id": "http://www.grid.ac/institutes/grid.417368.f", 
          "name": [
            "Division of Metabolism and Endocrinology, Department of Internal Medicine, Yokohama Sakae Kyosai Hospital, Yokohama, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tsunoda", 
        "givenName": "Tetsuji", 
        "id": "sg:person.01262277043.57", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01262277043.57"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Cardiology, Department of Internal Medicine, Yokohama Sakae Kyosai Hospital, Federation of National Public Service Personnel Mutual Associations, 132 Katsura-cho, Sakae-ku, 247-8581, Yokohama, Japan", 
          "id": "http://www.grid.ac/institutes/grid.417368.f", 
          "name": [
            "Division of Cardiology, Department of Internal Medicine, Yokohama Sakae Kyosai Hospital, Federation of National Public Service Personnel Mutual Associations, 132 Katsura-cho, Sakae-ku, 247-8581, Yokohama, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Katoh", 
        "givenName": "Hiromasa", 
        "id": "sg:person.01351172112.19", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01351172112.19"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Cardiology, Department of Internal Medicine, Yokohama Sakae Kyosai Hospital, Federation of National Public Service Personnel Mutual Associations, 132 Katsura-cho, Sakae-ku, 247-8581, Yokohama, Japan", 
          "id": "http://www.grid.ac/institutes/grid.417368.f", 
          "name": [
            "Division of Cardiology, Department of Internal Medicine, Yokohama Sakae Kyosai Hospital, Federation of National Public Service Personnel Mutual Associations, 132 Katsura-cho, Sakae-ku, 247-8581, Yokohama, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ito", 
        "givenName": "Shimpei", 
        "id": "sg:person.0715041437.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0715041437.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Cardiology, Department of Internal Medicine, Yokohama Sakae Kyosai Hospital, Federation of National Public Service Personnel Mutual Associations, 132 Katsura-cho, Sakae-ku, 247-8581, Yokohama, Japan", 
          "id": "http://www.grid.ac/institutes/grid.417368.f", 
          "name": [
            "Division of Cardiology, Department of Internal Medicine, Yokohama Sakae Kyosai Hospital, Federation of National Public Service Personnel Mutual Associations, 132 Katsura-cho, Sakae-ku, 247-8581, Yokohama, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Iwaki", 
        "givenName": "Taku", 
        "id": "sg:person.01177440754.61", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01177440754.61"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Cardiology, Department of Internal Medicine, Yokohama Sakae Kyosai Hospital, Federation of National Public Service Personnel Mutual Associations, 132 Katsura-cho, Sakae-ku, 247-8581, Yokohama, Japan", 
          "id": "http://www.grid.ac/institutes/grid.417368.f", 
          "name": [
            "Division of Cardiology, Department of Internal Medicine, Yokohama Sakae Kyosai Hospital, Federation of National Public Service Personnel Mutual Associations, 132 Katsura-cho, Sakae-ku, 247-8581, Yokohama, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Michishita", 
        "givenName": "Ichiro", 
        "id": "sg:person.0732262025.70", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0732262025.70"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1186/1479-5876-11-84", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050901664", 
          "https://doi.org/10.1186/1479-5876-11-84"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1475-2840-9-76", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014654111", 
          "https://doi.org/10.1186/1475-2840-9-76"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00380-015-0673-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021392537", 
          "https://doi.org/10.1007/s00380-015-0673-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00380-014-0610-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033497025", 
          "https://doi.org/10.1007/s00380-014-0610-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00380-014-0509-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026848532", 
          "https://doi.org/10.1007/s00380-014-0509-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00380-013-0429-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031208064", 
          "https://doi.org/10.1007/s00380-013-0429-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1475-2840-12-154", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052424543", 
          "https://doi.org/10.1186/1475-2840-12-154"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2015-08-21", 
    "datePublishedReg": "2015-08-21", 
    "description": "The clinical efficacy of glucagon-like peptide-1 (GLP-1) analogs in patients with acute myocardial infarction (AMI) is uncertain. The purpose of the present study was to evaluate the effects of the GLP-1 analog liraglutide on left ventricular (LV) remodeling in patients with AMI. We retrospectively evaluated the effects of liraglutide on LV remodeling assessed by cardiac magnetic resonance imaging (CMRI) in 15 patients with type 2 diabetes who were successfully treated with primary percutaneous coronary intervention (PCI) for AMI. Patients were divided into two groups based on their hypoglycemic medication: liraglutide use (group L; n\u00a0=\u00a06) or standard therapy (group S; n\u00a0=\u00a09). The CMRI findings in the early phase and at the 6-month follow-up were compared. At the 6-month follow-up, group S showed increases in LV end-diastolic (from 64 to 74\u00a0mL/m2, p\u00a0=\u00a00.08) and end-systolic (from 38 to 45\u00a0mL/m2, p\u00a0=\u00a00.13) volume indexes, whereas no such increase was observed in group L. The LV mass index (LVMI) was significantly smaller in group L than in group S at baseline (64 vs. 75\u00a0g/m2, p\u00a0=\u00a00.05) and at follow-up (56 vs. 78\u00a0g/m2, p\u00a0=\u00a00.009). Multivariate regression analysis showed that liraglutide use was an independent negative predictor of LVMI (\u03b2\u00a0=\u00a0\u22120.720, p\u00a0=\u00a00.003). In conclusion, liraglutide may be able to prevent the progression of LV remodeling and is associated with a lower LV mass in diabetic patients with AMI undergoing primary PCI.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00380-015-0734-5", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1095887", 
        "issn": [
          "0910-8327", 
          "1615-2573"
        ], 
        "name": "Heart and Vessels", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "8", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "31"
      }
    ], 
    "keywords": [
      "primary percutaneous coronary intervention", 
      "acute myocardial infarction", 
      "LV mass index", 
      "glucagon-like peptide-1 analog", 
      "cardiac magnetic resonance imaging", 
      "effects of liraglutide", 
      "percutaneous coronary intervention", 
      "peptide-1 analog", 
      "left ventricular", 
      "liraglutide use", 
      "coronary intervention", 
      "LV remodeling", 
      "myocardial infarction", 
      "group S", 
      "primary PCI", 
      "GLP-1 analogue liraglutide", 
      "lower LV mass", 
      "independent negative predictor", 
      "left ventricular remodeling", 
      "type 2 diabetes", 
      "cardiac magnetic resonance", 
      "multivariate regression analysis", 
      "magnetic resonance imaging", 
      "hypoglycemic medications", 
      "standard therapy", 
      "diabetic patients", 
      "clinical efficacy", 
      "mass index", 
      "cMRI findings", 
      "ventricular remodeling", 
      "LV mass", 
      "liraglutide", 
      "patients", 
      "group L.", 
      "group L", 
      "resonance imaging", 
      "volume index", 
      "negative predictor", 
      "infarction", 
      "regression analysis", 
      "remodeling", 
      "early phase", 
      "present study", 
      "intervention", 
      "magnetic resonance", 
      "such increase", 
      "medications", 
      "ventricular", 
      "diabetes", 
      "therapy", 
      "baseline", 
      "progression", 
      "efficacy", 
      "index", 
      "effect", 
      "predictors", 
      "increase", 
      "conclusion", 
      "imaging", 
      "group", 
      "findings", 
      "use", 
      "analogues", 
      "study", 
      "purpose", 
      "mass", 
      "analysis", 
      "L.", 
      "resonance", 
      "phase"
    ], 
    "name": "Effects of liraglutide, a glucagon-like peptide-1 analog, on left ventricular remodeling assessed by cardiac magnetic resonance imaging in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention", 
    "pagination": "1239-1246", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1001685894"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00380-015-0734-5"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "26293570"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00380-015-0734-5", 
      "https://app.dimensions.ai/details/publication/pub.1001685894"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-06-01T22:13", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220601/entities/gbq_results/article/article_660.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00380-015-0734-5"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00380-015-0734-5'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00380-015-0734-5'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00380-015-0734-5'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00380-015-0734-5'


 

This table displays all metadata directly associated to this object as RDF triples.

272 TRIPLES      22 PREDICATES      120 URIs      105 LITERALS      24 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00380-015-0734-5 schema:about N00d03767a86e427cb63d0ec6c7b81cde
2 N0ced6a622843421a9e20bbc7233ce755
3 N0e882f7fc4f940fca86b2616892eddde
4 N3929fab3b41e4357a3a1b9f5d1009001
5 N4d6b2af4a8164a999c7afc0f37492b29
6 N500a01393cf14dccac86d77d124ca371
7 N64cc969a800f4ab6be10fad3483c167f
8 N6e89e3e8007741f39917266f543ca145
9 N83d65a7bbee041c5b34663afcd906744
10 N99c086ca9b0b4c27a912c8d3a36a8702
11 Nb19037a9f152459c894e57c07b6b5eb2
12 Nc271bfa8e5a54f4783f03456b08b3e85
13 Nd8c37f22f03c4017883573b213c27721
14 Ndfdff4d700fc4d06b5c5c5e1c9b0e0f7
15 Ne91a4c9d4326434099624f1e2aa8805d
16 Nf2314b5c67084781840a014301ddcede
17 Nf9c2a73c33544b6487db0464ee826db9
18 anzsrc-for:11
19 anzsrc-for:1103
20 schema:author N29f1c079829841b2897be53b6f4fc22d
21 schema:citation sg:pub.10.1007/s00380-013-0429-8
22 sg:pub.10.1007/s00380-014-0509-4
23 sg:pub.10.1007/s00380-014-0610-8
24 sg:pub.10.1007/s00380-015-0673-1
25 sg:pub.10.1186/1475-2840-12-154
26 sg:pub.10.1186/1475-2840-9-76
27 sg:pub.10.1186/1479-5876-11-84
28 schema:datePublished 2015-08-21
29 schema:datePublishedReg 2015-08-21
30 schema:description The clinical efficacy of glucagon-like peptide-1 (GLP-1) analogs in patients with acute myocardial infarction (AMI) is uncertain. The purpose of the present study was to evaluate the effects of the GLP-1 analog liraglutide on left ventricular (LV) remodeling in patients with AMI. We retrospectively evaluated the effects of liraglutide on LV remodeling assessed by cardiac magnetic resonance imaging (CMRI) in 15 patients with type 2 diabetes who were successfully treated with primary percutaneous coronary intervention (PCI) for AMI. Patients were divided into two groups based on their hypoglycemic medication: liraglutide use (group L; n = 6) or standard therapy (group S; n = 9). The CMRI findings in the early phase and at the 6-month follow-up were compared. At the 6-month follow-up, group S showed increases in LV end-diastolic (from 64 to 74 mL/m2, p = 0.08) and end-systolic (from 38 to 45 mL/m2, p = 0.13) volume indexes, whereas no such increase was observed in group L. The LV mass index (LVMI) was significantly smaller in group L than in group S at baseline (64 vs. 75 g/m2, p = 0.05) and at follow-up (56 vs. 78 g/m2, p = 0.009). Multivariate regression analysis showed that liraglutide use was an independent negative predictor of LVMI (β = −0.720, p = 0.003). In conclusion, liraglutide may be able to prevent the progression of LV remodeling and is associated with a lower LV mass in diabetic patients with AMI undergoing primary PCI.
31 schema:genre article
32 schema:inLanguage en
33 schema:isAccessibleForFree false
34 schema:isPartOf Ncc399454eea94861b325a477f404576c
35 Nd0b38d627f9549259a82c25b9d56d121
36 sg:journal.1095887
37 schema:keywords GLP-1 analogue liraglutide
38 L.
39 LV mass
40 LV mass index
41 LV remodeling
42 acute myocardial infarction
43 analogues
44 analysis
45 baseline
46 cMRI findings
47 cardiac magnetic resonance
48 cardiac magnetic resonance imaging
49 clinical efficacy
50 conclusion
51 coronary intervention
52 diabetes
53 diabetic patients
54 early phase
55 effect
56 effects of liraglutide
57 efficacy
58 findings
59 glucagon-like peptide-1 analog
60 group
61 group L
62 group L.
63 group S
64 hypoglycemic medications
65 imaging
66 increase
67 independent negative predictor
68 index
69 infarction
70 intervention
71 left ventricular
72 left ventricular remodeling
73 liraglutide
74 liraglutide use
75 lower LV mass
76 magnetic resonance
77 magnetic resonance imaging
78 mass
79 mass index
80 medications
81 multivariate regression analysis
82 myocardial infarction
83 negative predictor
84 patients
85 peptide-1 analog
86 percutaneous coronary intervention
87 phase
88 predictors
89 present study
90 primary PCI
91 primary percutaneous coronary intervention
92 progression
93 purpose
94 regression analysis
95 remodeling
96 resonance
97 resonance imaging
98 standard therapy
99 study
100 such increase
101 therapy
102 type 2 diabetes
103 use
104 ventricular
105 ventricular remodeling
106 volume index
107 schema:name Effects of liraglutide, a glucagon-like peptide-1 analog, on left ventricular remodeling assessed by cardiac magnetic resonance imaging in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention
108 schema:pagination 1239-1246
109 schema:productId N77873b21218c460fb4450b2da7d589c6
110 Na60db88b373644b5ad804460c64701c4
111 Neb13a1d1499443029f3b9b068b7e062d
112 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001685894
113 https://doi.org/10.1007/s00380-015-0734-5
114 schema:sdDatePublished 2022-06-01T22:13
115 schema:sdLicense https://scigraph.springernature.com/explorer/license/
116 schema:sdPublisher N589a5959113d46f9ad1925f5cb9f3287
117 schema:url https://doi.org/10.1007/s00380-015-0734-5
118 sgo:license sg:explorer/license/
119 sgo:sdDataset articles
120 rdf:type schema:ScholarlyArticle
121 N00d03767a86e427cb63d0ec6c7b81cde schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Myocardial Infarction
123 rdf:type schema:DefinedTerm
124 N0193ee4299a34b3a8c863ceb461b4e17 rdf:first sg:person.01262277043.57
125 rdf:rest Ndebbd868175644c481479ed17f496811
126 N02d72427916643f781ac9ea955bedf2d rdf:first sg:person.0715041437.25
127 rdf:rest Nbe56b91e97f149e79dd8efe001a61f77
128 N0ced6a622843421a9e20bbc7233ce755 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Multivariate Analysis
130 rdf:type schema:DefinedTerm
131 N0e882f7fc4f940fca86b2616892eddde schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Humans
133 rdf:type schema:DefinedTerm
134 N29f1c079829841b2897be53b6f4fc22d rdf:first sg:person.01033145125.12
135 rdf:rest N8fcb3ac089e54157a6b198622866e466
136 N3929fab3b41e4357a3a1b9f5d1009001 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Pilot Projects
138 rdf:type schema:DefinedTerm
139 N4d6b2af4a8164a999c7afc0f37492b29 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Middle Aged
141 rdf:type schema:DefinedTerm
142 N500a01393cf14dccac86d77d124ca371 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Retrospective Studies
144 rdf:type schema:DefinedTerm
145 N589a5959113d46f9ad1925f5cb9f3287 schema:name Springer Nature - SN SciGraph project
146 rdf:type schema:Organization
147 N64cc969a800f4ab6be10fad3483c167f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Female
149 rdf:type schema:DefinedTerm
150 N6e89e3e8007741f39917266f543ca145 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Linear Models
152 rdf:type schema:DefinedTerm
153 N77873b21218c460fb4450b2da7d589c6 schema:name doi
154 schema:value 10.1007/s00380-015-0734-5
155 rdf:type schema:PropertyValue
156 N83d65a7bbee041c5b34663afcd906744 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Ventricular Function, Left
158 rdf:type schema:DefinedTerm
159 N8f7a74457e08461bb5c3ac410d651849 rdf:first sg:person.0732262025.70
160 rdf:rest rdf:nil
161 N8fcb3ac089e54157a6b198622866e466 rdf:first sg:person.01171603660.78
162 rdf:rest N0193ee4299a34b3a8c863ceb461b4e17
163 N99c086ca9b0b4c27a912c8d3a36a8702 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Diabetes Mellitus, Type 2
165 rdf:type schema:DefinedTerm
166 Na60db88b373644b5ad804460c64701c4 schema:name pubmed_id
167 schema:value 26293570
168 rdf:type schema:PropertyValue
169 Nb19037a9f152459c894e57c07b6b5eb2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Percutaneous Coronary Intervention
171 rdf:type schema:DefinedTerm
172 Nbe56b91e97f149e79dd8efe001a61f77 rdf:first sg:person.01177440754.61
173 rdf:rest N8f7a74457e08461bb5c3ac410d651849
174 Nc271bfa8e5a54f4783f03456b08b3e85 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
175 schema:name Magnetic Resonance Imaging
176 rdf:type schema:DefinedTerm
177 Ncc399454eea94861b325a477f404576c schema:issueNumber 8
178 rdf:type schema:PublicationIssue
179 Nd0b38d627f9549259a82c25b9d56d121 schema:volumeNumber 31
180 rdf:type schema:PublicationVolume
181 Nd8c37f22f03c4017883573b213c27721 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
182 schema:name Liraglutide
183 rdf:type schema:DefinedTerm
184 Ndebbd868175644c481479ed17f496811 rdf:first sg:person.01351172112.19
185 rdf:rest N02d72427916643f781ac9ea955bedf2d
186 Ndfdff4d700fc4d06b5c5c5e1c9b0e0f7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
187 schema:name Male
188 rdf:type schema:DefinedTerm
189 Ne91a4c9d4326434099624f1e2aa8805d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
190 schema:name Ventricular Remodeling
191 rdf:type schema:DefinedTerm
192 Neb13a1d1499443029f3b9b068b7e062d schema:name dimensions_id
193 schema:value pub.1001685894
194 rdf:type schema:PropertyValue
195 Nf2314b5c67084781840a014301ddcede schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
196 schema:name Aged
197 rdf:type schema:DefinedTerm
198 Nf9c2a73c33544b6487db0464ee826db9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
199 schema:name Japan
200 rdf:type schema:DefinedTerm
201 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
202 schema:name Medical and Health Sciences
203 rdf:type schema:DefinedTerm
204 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
205 schema:name Clinical Sciences
206 rdf:type schema:DefinedTerm
207 sg:journal.1095887 schema:issn 0910-8327
208 1615-2573
209 schema:name Heart and Vessels
210 schema:publisher Springer Nature
211 rdf:type schema:Periodical
212 sg:person.01033145125.12 schema:affiliation grid-institutes:grid.417368.f
213 schema:familyName Nozue
214 schema:givenName Tsuyoshi
215 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01033145125.12
216 rdf:type schema:Person
217 sg:person.01171603660.78 schema:affiliation grid-institutes:grid.417368.f
218 schema:familyName Yamada
219 schema:givenName Masayo
220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01171603660.78
221 rdf:type schema:Person
222 sg:person.01177440754.61 schema:affiliation grid-institutes:grid.417368.f
223 schema:familyName Iwaki
224 schema:givenName Taku
225 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01177440754.61
226 rdf:type schema:Person
227 sg:person.01262277043.57 schema:affiliation grid-institutes:grid.417368.f
228 schema:familyName Tsunoda
229 schema:givenName Tetsuji
230 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01262277043.57
231 rdf:type schema:Person
232 sg:person.01351172112.19 schema:affiliation grid-institutes:grid.417368.f
233 schema:familyName Katoh
234 schema:givenName Hiromasa
235 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01351172112.19
236 rdf:type schema:Person
237 sg:person.0715041437.25 schema:affiliation grid-institutes:grid.417368.f
238 schema:familyName Ito
239 schema:givenName Shimpei
240 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0715041437.25
241 rdf:type schema:Person
242 sg:person.0732262025.70 schema:affiliation grid-institutes:grid.417368.f
243 schema:familyName Michishita
244 schema:givenName Ichiro
245 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0732262025.70
246 rdf:type schema:Person
247 sg:pub.10.1007/s00380-013-0429-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031208064
248 https://doi.org/10.1007/s00380-013-0429-8
249 rdf:type schema:CreativeWork
250 sg:pub.10.1007/s00380-014-0509-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026848532
251 https://doi.org/10.1007/s00380-014-0509-4
252 rdf:type schema:CreativeWork
253 sg:pub.10.1007/s00380-014-0610-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033497025
254 https://doi.org/10.1007/s00380-014-0610-8
255 rdf:type schema:CreativeWork
256 sg:pub.10.1007/s00380-015-0673-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021392537
257 https://doi.org/10.1007/s00380-015-0673-1
258 rdf:type schema:CreativeWork
259 sg:pub.10.1186/1475-2840-12-154 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052424543
260 https://doi.org/10.1186/1475-2840-12-154
261 rdf:type schema:CreativeWork
262 sg:pub.10.1186/1475-2840-9-76 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014654111
263 https://doi.org/10.1186/1475-2840-9-76
264 rdf:type schema:CreativeWork
265 sg:pub.10.1186/1479-5876-11-84 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050901664
266 https://doi.org/10.1186/1479-5876-11-84
267 rdf:type schema:CreativeWork
268 grid-institutes:grid.417368.f schema:alternateName Division of Cardiology, Department of Internal Medicine, Yokohama Sakae Kyosai Hospital, Federation of National Public Service Personnel Mutual Associations, 132 Katsura-cho, Sakae-ku, 247-8581, Yokohama, Japan
269 Division of Metabolism and Endocrinology, Department of Internal Medicine, Yokohama Sakae Kyosai Hospital, Yokohama, Japan
270 schema:name Division of Cardiology, Department of Internal Medicine, Yokohama Sakae Kyosai Hospital, Federation of National Public Service Personnel Mutual Associations, 132 Katsura-cho, Sakae-ku, 247-8581, Yokohama, Japan
271 Division of Metabolism and Endocrinology, Department of Internal Medicine, Yokohama Sakae Kyosai Hospital, Yokohama, Japan
272 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...